Department of Pharmacology Archive — Page 10 of 13
-
June 17, 2015
Lit up COX-2 cancer probe
A new imaging probe developed by Vanderbilt investigators enhances tumor visibility and has broad applications in diagnosing and monitoring patients with cancer. -
June 12, 2015
New strategy to combat HIV
Inhibitors of the enzyme phospholipase D1 suppress the replication of HIV-1, Vanderbilt investigators have discovered. -
May 7, 2015
Findings reveal new target in quest to ease schizophrenia
Vanderbilt University researchers have uncovered a surprising finding that could lead to the development of new, more effective therapies for schizophrenia, which affects more than 2 million Americans. -
May 6, 2015
Neurofibromin fine-tunes bone growth
The protein neurofibromin acts as a brake in a signaling pathway that is important in bone development, Vanderbilt researchers have discovered. -
April 23, 2015
Lecture explores efforts to move pharmacogenetics into the clinic
Preemptive genotyping: It sounds like a surprise attack, and it is. -
April 3, 2015
Cancer signaling pathway blocker
Researchers at Vanderbilt University have discovered a new way to inhibit Hedgehog (Hh) signaling, an important regulatory pathway for vertebrate development – and cancer. -
April 2, 2015
Pharmacogenomics expert set for Wilkinson Lecture
Mary Relling, Pharm.D., chair of the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital in Memphis, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology on Thursday, April 9.